Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Systemic Amyloidosis (AL)”

170 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 170 results

Testing effectiveness (Phase 2)Looking for participantsNCT05145816
What this trial is testing

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

Who this might be right for
AL AmyloidosisAmyloidosis
University of Texas Southwestern Medical Center 37
Large-scale testing (Phase 3)Study completedNCT00344526
What this trial is testing

Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis

Who this might be right for
Primary Systemic Amyloidosis (AL)
University Hospital, Limoges 100
Not applicableWithdrawnNCT06769555
What this trial is testing

BCMA/CD3 BiTE for RRAL or NDAL Amyloidosis With Insufficient Depth of Hematologic Response After Induction Therapy

Who this might be right for
AL Amyloidosis
Institute of Hematology & Blood Diseases Hospital, China
Testing effectiveness (Phase 2)Study completedNCT01570387
What this trial is testing

A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis

Who this might be right for
AL Amyloidosis
Boston Medical Center 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT04270175
What this trial is testing

Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab

Who this might be right for
AmyloidAL AmyloidosisRefractory AL Amyloidosis
Weill Medical College of Cornell University 15
Not applicableStudy completedNCT07585331
What this trial is testing

Towards Effective, Patient-tailored Anti-plasma Cell Therapies in AL Amyloidosis: Predicting Drug Response and Overcoming Drug Resistance

Who this might be right for
AL Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 250
Large-scale testing (Phase 3)Study completedNCT04298372
What this trial is testing

Frontline Lenalidomide for AL Amyloidosis Involving Myocardium

Who this might be right for
Amyloidosis Cardiac
Seoul National University Hospital 2
Testing effectiveness (Phase 2)UnknownNCT03252600
What this trial is testing

Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis

Who this might be right for
Recurrent Primary Amyloidosis
Barbara Ann Karmanos Cancer Institute 53
Testing effectiveness (Phase 2)Ended earlyNCT03154047
What this trial is testing

Study in Subjects With Light Chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
Prothena Biosciences Ltd. 80
Not applicableLooking for participantsNCT06855121
What this trial is testing

The Norwegian Immunotherapy in Multiple Myeloma Study

Who this might be right for
Myeloma MultiplePlasma Cell LeukemiaAL Amyloidosis
St. Olavs Hospital 400
Early research (Phase 1)Study completedNCT01815086
What this trial is testing

Radioimmunoimaging of Light Chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
University of Tennessee 30
Testing effectiveness (Phase 2)Study completedNCT03678259
What this trial is testing

124I-p5+14 Injection Safety in Subjects With Systemic Amyloidosis

Who this might be right for
Systemic Amyloidosis
University of Tennessee Graduate School of Medicine 57
Not applicableStudy completedNCT02555969
What this trial is testing

Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis

Who this might be right for
AmyloidosisPrimary Amyloidosis
Tufts Medical Center 56
Testing effectiveness (Phase 2)Study completedNCT03236792
What this trial is testing

Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis

Who this might be right for
AL Amyloidosis
Icahn School of Medicine at Mount Sinai 28
Not applicableUnknownNCT06048601
What this trial is testing

18F-florbetaben PET-CT to Non-invasively Diagnose Cardiac AL Amyloidosis

Who this might be right for
AmyloidAmyloid Cardiomyopathy
Fondazione Toscana Gabriele Monasterio 150
Not applicableNot Yet RecruitingNCT07624760
What this trial is testing

Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging

Who this might be right for
Monoclonal GammopathyMonoclonal Gammopathy of Undetermined Significance (MGUS)Multiple Myeloma+2 more
University of Zurich 50
Not applicableStudy completedNCT02055534
What this trial is testing

Nutritional Counseling in Systemic Immunoglobulin Light-chain Amyloidosis

Who this might be right for
Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 144
Early research (Phase 1)Study completedNCT01409148
What this trial is testing

Radioimmunoimaging of AL Amyloidosis

Who this might be right for
AL Amyloidosis
University of Tennessee 38
Not applicableLooking for participantsNCT06971848
What this trial is testing

Evaluation of Skin Tests in Biotherapy Allergies

Who this might be right for
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckMelanoma NeoplasmsSmall Cell Bronchial Carcinomas+13 more
University Hospital, Angers 70
Not applicableLooking for participantsNCT07172243
What this trial is testing

BE.Amycon Biobank & Data Registry UZ Leuven

Who this might be right for
AmyloidosisAL AmyloidosisAmyloidosis Cardiac
Universitaire Ziekenhuizen KU Leuven 505
Load More Results